Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.

Antimicrobial Agents and Chemotherapy
S ChamberlandL E Bryan

Abstract

Mechanisms of resistance to quinolones were characterized in Pseudomonas aeruginosa strains isolated after Tn5 insertional mutagenesis and in resistant strains that emerged during pefloxacin therapy of experimental aortic endocarditis. Quinolone resistance achieved in in vitro-selected mutants Qr-1 and Qr-2 was associated with cross-resistance to several groups of antimicrobial agents, including beta-lactams, tetracycline, and chloramphenicol. A significant reduction of norfloxacin uptake was also observed. After ether permeabilization of the cells, DNA synthesis of these two isolates was as susceptible to norfloxacin as DNA synthesis of the parent strain (PAO1). These results indicate that alteration of outer membrane permeability is the primary determinant of resistance in these isolates. This altered cell permeability was correlated with reduction of outer membrane protein G (25.5 kilodaltons) and loss of a 40-kilodalton outer membrane protein in strain Qr-1. Resistance to quinolones that emerged during experimental endocarditis therapy was associated with both modification of outer membrane permeability (decreased uptake of norfloxacin) and decreased susceptibility of DNA synthesis to norfloxacin. Resistance was limited to ...Continue Reading

References

Jan 1, 1979·Antimicrobial Agents and Chemotherapy·R S ConradD L Clay
Dec 1, 1979·Journal of Bacteriology·R E Hancock, A M Carey
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Mar 30, 1976·Molecular & General Genetics : MGG·D Haas, B W Holloway
Aug 1, 1987·Antimicrobial Agents and Chemotherapy·A J Godfrey, L E Bryan
Sep 1, 1987·Antimicrobial Agents and Chemotherapy·J BedardL E Bryan
Jan 1, 1988·Reviews of Infectious Diseases·D C Hooper, J S Wolfson
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·N J Robillard, A L Scarpa
Oct 1, 1985·Antimicrobial Agents and Chemotherapy·J S Wolfson, D C Hooper
Apr 1, 1986·Antimicrobial Agents and Chemotherapy·D C HooperM N Swartz
Jan 1, 1986·Antimicrobial Agents and Chemotherapy·D M Benbrook, R V Miller
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·S P CohenS B Levy
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·K HiraiS Mitsuhashi
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·J S Chapman, N H Georgopapadakou
Sep 1, 1987·Molecular and Cellular Probes·F Malouin, L E Bryan
Aug 1, 1986·Antimicrobial Agents and Chemotherapy·K HiraiS Mitsuhashi
Nov 15, 1973·Journal of Molecular Biology·U K Laemmli, M Favre
May 10, 1974·Annals of the New York Academy of Sciences·L Leive
Feb 1, 1964·The Biochemical Journal·V P SkipskiM Barclay
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·K DrlicaS H Manes
Jan 1, 1981·Annual Review of Biochemistry·M Gellert
Nov 1, 1981·Journal of Bacteriology·R S Conrad, H E Gilleland
Jan 1, 1983·Journal of Bacteriology·H NikaidoJ Foulds
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·Y KobayashiT Nakae

❮ Previous
Next ❯

Citations

Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L E Bryan, J Bedard
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W M Scheld
Jan 1, 1993·International Journal of Antimicrobial Agents·A Bryskier
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·K GensbergR E Hancock
Feb 1, 1996·Journal of Veterinary Pharmacology and Therapeutics·S A Brown
Nov 1, 1989·Antimicrobial Agents and Chemotherapy·R A Celesk, N J Robillard
Oct 1, 1990·Antimicrobial Agents and Chemotherapy·N J Robillard
Feb 1, 1990·Antimicrobial Agents and Chemotherapy·B L MasecarN J Robillard
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·H YoshidaS Nakamura
Sep 1, 1990·Antimicrobial Agents and Chemotherapy·H FukudaS Iyobe
Oct 1, 1991·Antimicrobial Agents and Chemotherapy·M Michéa-HamzehpourJ C Pechère
Dec 1, 1991·Antimicrobial Agents and Chemotherapy·N NakanishiS Mitsuhashi
Feb 1, 1991·Antimicrobial Agents and Chemotherapy·S YoshidaS Mitsuhashi
Mar 11, 1991·Antimicrobial Agents and Chemotherapy·F MalouinT R Parr
Mar 1, 1991·Antimicrobial Agents and Chemotherapy·M Michea-HamzehpourJ C Pechere
Jun 1, 1991·Antimicrobial Agents and Chemotherapy·N NakanishiS Mitsuhashi
May 1, 1992·Antimicrobial Agents and Chemotherapy·L J PiddockR E Hancock
Aug 1, 1992·Antimicrobial Agents and Chemotherapy·C McCaffreyN H Georgopapadakou
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·N Masuda, S Ohya
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·N NakadaM Arisawa
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·T YoshidaS Mitsuhashi
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·H FukudaK Hirai
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·K Poole
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·P M FurneriG Tempera
Mar 30, 2013·Microbial Cell Factories·Stéphanie FollonierMaría Auxiliadora Prieto
Mar 6, 2009·Journal of Drug Targeting·Xinke ZhangGuihua Huang
Jul 1, 1990·Molecular Microbiology·R E HancockN Martin
Feb 28, 1991·The New England Journal of Medicine·G A Jacoby, G L Archer
May 26, 2005·The Journal of Antimicrobial Chemotherapy·Keith Poole

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

Antimicrobial Agents and Chemotherapy
M Michéa-HamzehpourJ C Pechére
© 2022 Meta ULC. All rights reserved